Veracyte Inc (VCYT)

Inventory turnover

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Cost of revenue (ttm) US$ in thousands 156,616 154,864 156,218 146,858 137,618 128,663 118,573 110,358 108,756 104,098 101,582 97,633 93,268 85,710 74,400 62,705 51,432 41,615 41,455 40,387
Inventory US$ in thousands 25,020 24,254 21,750 20,364 19,258 18,328 16,128 15,887 11,572 13,306 14,294 13,798 14,600 12,372 11,225 9,824 6,674 6,308 4,657 4,456
Inventory turnover 6.26 6.39 7.18 7.21 7.15 7.02 7.35 6.95 9.40 7.82 7.11 7.08 6.39 6.93 6.63 6.38 7.71 6.60 8.90 9.06

June 30, 2025 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $156,616K ÷ $25,020K
= 6.26

The inventory turnover ratio for Veracyte Inc. demonstrates notable fluctuations over the analyzed period. At the beginning of the observed timeframe, on September 30, 2020, the ratio was relatively high at 9.06, indicating efficient management of inventory relative to sales during that period. This ratio experienced a slight decline to 8.90 by the end of 2020, maintaining a generally stable trend.

In the subsequent quarters, a gradual decrease in inventory turnover is observed, reaching a low of 6.38 on September 30, 2021. This decline suggests that inventory was being converted into sales at a slower rate, potentially due to increased inventory levels, reduced sales efficiency, or strategic inventory buildup.

From late 2021 to mid-2022, the ratio shows some recovery, rising back to around 6.93 by March 2022 and maintaining a relatively stable range thereafter. Specifically, the ratio increased to 7.11 at the end of 2022 and further to 7.82 by March 2023, reflecting a moderate improvement in inventory management.

A significant upward movement occurs between June 2023 and September 2023, where the ratio peaks at 9.40, the highest in the period examined. This suggests a period of more efficient inventory utilization or possibly reduced inventory holdings relative to sales. However, post-September 2023, the ratio declines again to 6.95 by the end of 2023, indicating a reversal of the earlier improvement. It remains relatively stable through early 2024, fluctuating around 7.15, before slightly decreasing to 6.39 by March 2025.

Overall, the trend indicates periods of both inventory accumulation and efficiency, with notable peaks and troughs. The substantial fluctuation, particularly the peak in mid-2023, could be indicative of strategic inventory adjustments, supply chain considerations, or changes in sales dynamics. The recent lower ratios may warrant further analysis to determine whether these reflect intentional inventory reductions or potential challenges in inventory turnover efficiency.


Peer comparison

Jun 30, 2025

Jun 30, 2025